Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 89,038 shares at $2.66 ($237K) on 2022-08-09, disclosed to the SEC on 2022-08-10.
Open-market sale of $237k PRTK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.66 | 44,519 | $118K | 50.0% |
| 2 | $2.66 | 44,519 | $118K | 50.0% |
| Total | $2.66 avg | 89,038 | $237K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $753K | — | Filing → |